enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. US FDA approves Dupixent to treat younger kids with ... - AOL

    www.aol.com/news/us-fda-approves-dupixent-treat...

    (Reuters) -The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to treat an allergic inflammation of the esophagus in children aged one to 11 years old and weighing at ...

  3. Dupilumab - Wikipedia

    en.wikipedia.org/wiki/Dupilumab

    Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis. [6][7][8][4] It is also used for the treatment of eosinophilic esophagitis [9] and prurigo nodularis. [10]

  4. Atopic dermatitis - Wikipedia

    en.wikipedia.org/wiki/Atopic_dermatitis

    While the condition may occur at any age, it typically starts in childhood, with changing severity over the years. [2] [3] In children under one year of age, the face and limbs and much of the body may be affected. [3] As children get older, the areas on the insides of the knees and folds of the elbows and around the neck are most commonly ...

  5. UK Drug Regulator Warns Of Severe Eye Reactions ... - AOL

    www.aol.com/news/uk-drug-regulator-warns-severe...

    The UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related side effects following the use of Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's ...

  6. Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

    www.aol.com/news/us-fda-approves-sanofi...

    Sanofi last year recorded a combined 10.72 billion euros ($11.94 billion) in sales for Dupixent, which is already used to treat immune system-related conditions such as asthma and eczema in the U ...

  7. Press Release: Dupixent recommended for EU approval by the ...

    lite.aol.com/tech/story/0022/20240920/1000993028.htm

    The positive CHMP opinion is supported by a two-part (Part A and B) EoE KIDS phase 3 study in children aged one to 11 years. In Part A, a significantly greater proportion of children receiving weight-based doses of Dupixent achieved histological disease remission at week 16, compared to placebo, with results sustained for up to one year in Part B.

  8. Myopia - Wikipedia

    en.wikipedia.org/wiki/Myopia

    A study of 2,523 children in grades 1 to 8 (age, 5–17 years) found nearly one in 10 (9%) have at least −0.75 diopters of myopia. [142] In this study, 13% had at least +1.25 D hyperopia (farsightedness), and 28% had at least 1.00-D difference between the two principal meridians (cycloplegic autorefraction) of astigmatism .

  9. Ketotifen - Wikipedia

    en.wikipedia.org/wiki/Ketotifen

    Ketotifen is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives).Ketotifen is available in ophthalmic (eye drops or drug-eluting contact lenses) and oral (tablets or syrup) forms: the ophthalmic form relieves eye itchiness and irritation associated with seasonal allergies, while the oral form helps ...